Reuters -- The world's biggest insulin producer Novo Nordisk reported a bigger-than-forecast rise in operating profits for the third quarter, but its shares fell as analysts said new 2010 guidance missed expectations.
Reuters -- The world's biggest insulin producer Novo Nordisk reported a bigger-than-forecast rise in operating profits for the third quarter, but its shares fell as analysts said new 2010 guidance missed expectations.
